Arife Unal Eroglu
Papers
1
Total Citations
50
H-Index
1
About
Arife Unal Eroglu is a pioneering researcher in the field of whole-organism drug discovery, with a focus on developing high-throughput screening platforms that bridge the gap between in vitro assays and in vivo efficacy. Her most notable contribution is the creation of ARQiv-HTS, a versatile whole-organism screening platform that enables in vivo drug discovery at unprecedented high-throughput rates. This innovative system, detailed in her highly cited 2016 paper (50 citations), allows researchers to rapidly test thousands of compounds in living organisms, significantly accelerating the identification of potential therapeutics. By integrating automation with zebrafish-based models, Eroglu’s work has revolutionized early-stage drug development, reducing reliance on traditional cell-based assays and improving translational relevance. Her achievements highlight a commitment to advancing preclinical methodologies, making her a key figure in the integration of biology and technology for pharmaceutical innovation.
Research Focus
Key Achievements
Top Papers
- 1